MicroPort Scientific (HK:0853) has released an update.
MicroPort Scientific Corporation has announced that its revolutionary Firesorb Bioresorbable Scaffold System, designed to treat coronary artery diseases, has received marketing approval from China’s National Medical Products Administration (NMPA). The Firesorb Stent stands out for its reduced strut thickness comparable to metal stents, extremely low thrombosis rates, and innovative ‘target eluting’ technology, allowing for wider lesion coverage and enhanced treatment of small-vessel lesions.
For further insights into HK:0853 stock, check out TipRanks’ Stock Analysis page.
